d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Phase I Parallel Protocol of MK-8669 (Ridaforolimus) + MK-2206 and MK-8669 (Ridaforolimus) + MK-0752 Doublets (MKMK)in Patients with Advanced Cancer [Country] NO [Cancer type] 
Multiple diagnosis
Nordic NECT - Inclusion completed
Cancer type